Clinical trial IJB_3786
Long-term Follow-up Protocol for Subjects treated with Gene-modified T-cells
| Organ | Myeloma |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2/3 |
| Academic trial | Non |
| Sponsor | Celgene |
| EudraCT Identifier | 2023-504201-36-00 |
| Last update |